Tulane-Led Study First to Confirm Effectiveness and Safety of New Treatment for Hemophilia
Tulane UniversityAn international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, has found that a drug commonly used to treat bleeding events in people with a type of severe hemophilia can also be used to prevent such events from happening in the first place.